Is produced by chemically splitting heparin into pieces of about one-third of its original size. fewer side effects, longer half-life, and a more predictable dose-dependent response, NO MONITORING req. INHIBITS FACTOR 10a Therapeutic use • Prevention of DVT following surgery • Treatment of established DVT • Prevention of ischemic complications Adverse effects and interactions • Bleeding • thrombocytopenia